Affluent Medical SA (FR:AFME) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Affluent Medical, a French medtech firm, has detailed its share capital and voting rights while outlining its goals to lead in structural heart diseases and urinary incontinence treatments. The company, which is developing innovative, minimally invasive implants, plans to market its products by 2026 contingent on successful clinical trials and funding. The latest share count stands at 39,348,021 with 55,586,576 theoretical voting rights and 55,412,507 exercisable voting rights.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.